Answer
Zanamivir selectively inhibits viral neuraminidase, reducing the spread of influenza A and B viruses by blocking the release of infectious virus particles from respiratory tract epithelial cells.
Sources for this answer
- Relenza 5mg/dose inhalation powder.GlaxoSmithKline UK · emc · SmPC §5.1 Pharmacodynamic properties · Version 26Document updated
Sources checked